CAS 301177-43-5

ESI-08

CAS: 301177-43-5

ESI-08

Reinheit: ≥95%

Molekulargewicht: 353.48g/mol

Ref: 54-BUP01612

ESI-08

CAS: 301177-43-5

ESI-08 is a drug that has been shown to have potent anti-cancer effects. It is a novel compound that inhibits the protein kinase AKT, which is an important mediator of the metabolic, proliferative, and survival pathways in mammalian cells. ESI-08 also has inhibitory activities on cardiac arrhythmia and cardiac hypertrophy. This drug colocalizes with mitochondria in cardiac cells, suggesting that it may be used as a mitochondrial targeting agent. ESI-08 has also been shown to have potent antagonistic effects against cancer cells, inhibiting their proliferation and inducing apoptosis.

Formel: C₂₀H₂₃N₃OS

Reinheit: Min. 95%

Molekulargewicht: 353.5 g/mol

Ref: 3D-BMA17743

ESI-08

CAS: 301177-43-5

ESI-08 is an effective antagonist of EPAC2 with an IC50 of 8.4 μM. ESI-08 selectively blocks cAMP-induced EPAC activation but not cAMP-mediated PKA activation.

Formel: C₂₀H₂₃N₃OS

Reinheit: 97.17%

Farbe und Form: Solid

Molekulargewicht: 353.48

Ref: TM-T11234